GlassScriptPhysician profile
Joseph N Gressock
NPI 1376654129
$925.23
in general payments reported to CMS, 2019-2025
21 companies · $55.68 in 2025
The $55.68 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $96.83 · 2021: $76.51 · 2022: $53.54 · 2023: $349 · 2024: $35.85 · 2025: $55.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $440.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $240.76 | 2019-2023 | |
| Medtronic, INC. | $216.82 | 2023 | Interstim, Truclear |
| Daiichi Sankyo INC. | $94.86 | 2019-2020 | |
| Lsi Solutions INC | $55.68 | 2025 | Cor-Knot |
| Astellas Pharma US INC | $40.93 | 2023-2024 | Veozah |
| Meditrina | $32.46 | 2023 | |
| Glaxosmithkline, LLC. | $30.46 | 2023-2024 | Trelegy Ellipta |
| Avanos Medical | $28.38 | 2019 | |
| Hologic Sales and Service, LLC | $19.23 | 2021 | |
| Exact Sciences Corporation | $16.58 | 2023 | Cologuard Collection Kit |
| Novo Nordisk INC | $15.61 | 2023 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $15.29 | 2020 | |
| Evofem Biosciences, INC. | $14.73 | 2023 | Phexxi |
| Scynexis, INC. | $14.26 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.06 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $13.64 | 2022 | |
| Dysis Medical, INC. | $13.29 | 2022 | |
| Exeltis, USA INC. | $12.35 | 2022 | |
| Amgen INC. | $12.34 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.00 | 2019 | |
| Minerva Surgical, INC | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Gressock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.